Esperion Therapeutics (ESPR) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known ...
Read Our Latest Analysis on ESPR Esperion Therapeutics Trading Up 6.3 % Shares of NASDAQ ESPR opened at $1.69 on Thursday. Esperion Therapeutics has a 12-month low of $1.56 and a 12-month high of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback